Invistics is a 20 y.o. company located in Atlanta, Georgia that has successfully launched an intelligent, machine driven technology for drug diversion detection. In 2017 Invistics won an NIH and launched Flowlytics after a successful initial phase. The focus of the NIH grant is improving the effectiveness and efficiency of drug diversion detection and management across any health setting.